One of the best ways to diagnose breast cancer early, aid in treatment decisions, or predict treatment response is to use cancer biomarkers.
HER2-positive early breast cancer molecular biomarkers are a key research area for Associate Professor Aleix Prat.
He explains that investigating HER2-positive early breast cancer is important as it can become an aggressive disease if left untreated. Find out more in this episode.
